Compare · AMEH vs EXPO
AMEH vs EXPO
Side-by-side comparison of Apollo Medical Holdings Inc. (AMEH) and Exponent Inc. (EXPO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AMEH and EXPO operate in Professional Services (Consumer Discretionary), so they compete in similar markets.
- EXPO is the larger of the two at $2.89B, about 1.1x AMEH ($2.62B).
- EXPO has hit the wire 8 times in the past 4 weeks while AMEH has been quiet.
- AMEH has more recent analyst coverage (9 ratings vs 2 for EXPO).
- Company
- Apollo Medical Holdings Inc.
- Exponent Inc.
- Price
- $40.83-2.20%
- $59.26-0.69%
- Market cap
- $2.62B
- $2.89B
- 1M return
- -
- -6.66%
- 1Y return
- -
- -23.41%
- Industry
- Professional Services
- Professional Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 0
- 8
- Recent ratings
- 9
- 2
Apollo Medical Holdings Inc.
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare management company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.
Exponent Inc.
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 different technical disciplines to solve complicated issues facing industry and government. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.
Latest AMEH
- Apollo Medical Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
- Apollo Medical Hlgs Q4 2023 GAAP EPS $0.26 Beats $0.15 Estimate, Sales $353.04M Beat $340.61M Estimate
- Apollo Medical Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Apollo Medical Hlgs's Earnings Outlook
- Jefferies Initiates Coverage On Apollo Medical Hlgs with Buy Rating, Announces Price Target of $50
- Apollo Medical Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- Apollo shares are trading higher after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $44 to $55.
- B of A Securities Upgrades Apollo Medical Hlgs to Buy, Raises Price Target to $55
- Apollo Medical upgraded by BofA Securities with a new price target
- Apollo Medical Holdings Announced That It Will Formally Change Its Name From Apollo Medical Holdings, Inc. To Astrana Health, Inc. And Will Begin Trading Under The Ticker Symbol "ASTH", Both Effective February 26, 2024
Latest EXPO
- Exponent to Participate in a Fireside Chat at the Wells Fargo 16th Annual Industrials & Materials Conference
- Director Lindstrom Carol converted options into 2,009 shares, increasing direct ownership by 27% to 9,405 units (SEC Form 4)
- Director Richardson Karen A converted options into 2,009 shares (SEC Form 4)
- Director Brown George H. converted options into 2,009 shares, increasing direct ownership by 23% to 10,730 units (SEC Form 4)
- Director Zumwalt Debra converted options into 2,009 shares, increasing direct ownership by 7% to 31,830 units (SEC Form 4)
- Director Johnston Paul R converted options into 2,009 shares, increasing direct ownership by 3% to 62,940 units (SEC Form 4)
- Group Vice President James Bradley A sold $114,930 worth of shares (2,000 units at $57.47), decreasing direct ownership by 64% to 1,105 units (SEC Form 4)
- Group Vice President Reiss Richard sold $98,062 worth of shares (1,672 units at $58.65), decreasing direct ownership by 42% to 2,288 units (SEC Form 4)
- President & CEO Corrigan Catherine exercised 5,606 shares at a strike of $26.95 and sold $226,726 worth of shares (4,194 units at $54.06), increasing direct ownership by 1% to 105,771 units (SEC Form 4)
- Group Vice President Rakow Joseph sold $160,974 worth of shares (2,945 units at $54.66), closing all direct ownership in the company (SEC Form 4)